Literature DB >> 2217530

Pharmacology of drugs that alter multidrug resistance in cancer.

J M Ford1, W N Hait.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2217530

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN： 0031-6997            Impact factor:   25.468


× No keyword cloud information.
  188 in total

1.  Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

Authors:  R B Kim; C Wandel; B Leake; M Cvetkovic; M F Fromm; P J Dempsey; M M Roden; F Belas; A K Chaudhary; D M Roden; A J Wood; G R Wilkinson
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

2.  Multidrug resistance transporters in the olfactory receptor neurons of Xenopus laevis tadpoles.

Authors:  Ivan Manzini; Detlev Schild
Journal:  J Physiol       Date:  2003-01-15       Impact factor: 5.182

Review 3.  Structure and function of efflux pumps that confer resistance to drugs.

Authors:  M Ines Borges-Walmsley; Kenneth S McKeegan; Adrian R Walmsley
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

4.  Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells.

Authors:  Federica Barbieri; Angela Alama; Bruno Tasso; Vito Boido; Cristina Bruzzo; Fabio Sparatore
Journal:  Invest New Drugs       Date:  2003-11       Impact factor: 3.850

Review 5.  Drug resistance in oncology: from concepts to applications.

Authors:  J L Cazin; P Gosselin; P Cappelaere; J Robert; A Demaille
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  Saracatinib (AZD0530) is a potent modulator of ABCB1-mediated multidrug resistance in vitro and in vivo.

Authors:  Ke-Jun Liu; Jie-Hua He; Xiao-Dong Su; Hong-May Sim; Jing-Dun Xie; Xing-Gui Chen; Fang Wang; Yong-Ju Liang; Satyakam Singh; Kamlesh Sodani; Tanaji T Talele; Suresh V Ambudkar; Zhe-Sheng Chen; Hai-Ying Wu; Li-Wu Fu
Journal:  Int J Cancer       Date:  2012-06-13       Impact factor: 7.396

Review 7.  Nanomedicinal strategies to treat multidrug-resistant tumors: current progress.

Authors:  Xiaowei Dong; Russell J Mumper
Journal:  Nanomedicine (Lond)       Date:  2010-06       Impact factor: 5.307

8.  The anti-leukemic effect of carnosic acid combined with adriamycin in a K562/A02/SCID leukemia mouse model.

Authors:  Lu-Qun Wang; Ran Wang; Xiang-Xin Li; Xiao-Ning Yu; Xue-Liang Chen; Hao Li
Journal:  Int J Clin Exp Med       Date:  2015-07-15

9.  Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.

Authors:  M Kourti; N Vavatsi; N Gombakis; V Sidi; G Tzimagiorgis; T Papageorgiou; D Koliouskas; F Athanassiadou
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

10.  Transferrin-Modified Vitamin-E/Lipid Based Polymeric Micelles for Improved Tumor Targeting and Anticancer Effect of Curcumin.

Authors:  Omkara Swami Muddineti; Preeti Kumari; Balaram Ghosh; Swati Biswas
Journal:  Pharm Res       Date:  2018-03-14       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.